Animal & Veterinary
VMAC Seeks Nominations
FDA Veterinarian Newsletter March/April 2003 Volume XVIII, No 2
FDA is requesting nominations for voting members to serve on the Veterinary Medicine Advisory Committee (VMAC) in one of the following specialty areas: Companion Animal Medicine, Chemistry, Biostatistics, and Consumer representative. Information regarding the committee can be found on the CVM home page.
FDA has a special interest in ensuring that women, minority groups, and the physically challenged are adequately represented on advisory committees and, therefore, encourages nominations of qualified candidates from these groups.
All nominations and curricula vitae with the exception of the consumer representative should be sent to Aleta Sindelar, Center for Veterinary Medicine, Food and Drug Administration, 7519 Standish Pl., Rockville, MD 20855, 301-827-4515, e-mail: email@example.com. The submission deadline will be announced in the Federal Register Notice.
Nominations for Consumer representatives should be sent to the attention of Dr. Linda A. Sherman, Advisory Committee Oversight and Management Staff (HF-4), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857.
Persons nominated for membership on the committee shall have adequate specialized training and experience necessary to qualify the nominee as an expert suitable for appointment. The nomination is subject to review, and may include experience in medical practice, teaching, and/or research relevant to the field of activity of the committee. The term of office is four years. Any interested person may nominate one or more qualified persons for membership on one or more of the advisory committees. Self-nominations are also accepted.
Nominations shall include the name of the committee, a complete curriculum vitae of each nominee, current business address, and telephone number, and shall state that the nominee is aware of the nomination, is willing to serve as a member, and appears to have no conflict of interest that would preclude membership. FDA will ask the potential candidates to provide detailed information concerning such matters as financial holdings, employment, and research grants and/or contracts to permit evaluation of possible sources of conflict of interest.